| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TAL bHLH transcription factor 1, erythroid differentiation factor | 0.505 | 0.731 | 0.57 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 1989 | 2017 | ||||||||
|
alpha-2-macroglobulin | 0.529 | 0.769 | 4.5E-11 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1989 | 2012 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
disease | 0.400 | None | 1.000 | 98 | 0 | 1990 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.100 | None | 0.903 | 31 | 1 | 1990 | 2019 | ||||||||
|
interferon beta 1 | 0.421 | 0.846 |
|
disease | 0.400 | None | 1.000 | 29 | 0 | 1990 | 2019 | |||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.100 | None | 0.880 | 25 | 2 | 1990 | 2019 | ||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.100 | None | 0.952 | 21 | 0 | 1990 | 2019 | |||||||||
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
disease | 0.100 | None | 0.955 | 18 | 0 | 1990 | 2020 | ||||||||
|
SRC proto-oncogene, non-receptor tyrosine kinase | 0.467 | 0.885 | 1.00 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1990 | 2019 | ||||||||
|
microphthalmia or anophthalmia and associated anomalies | 0.666 | 0.577 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1990 | 2008 | |||||||||
|
TIMP metallopeptidase inhibitor 2 | 0.425 | 0.846 | 0.79 |
|
disease | 0.040 | None | 1.000 | 3 | 0 | 1990 | 2014 | ||||||||
|
MYCN proto-oncogene, bHLH transcription factor | 0.454 | 0.808 | 0.89 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1990 | 2001 | ||||||||
|
nuclear receptor coactivator 1 | 0.563 | 0.731 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1990 | 2011 | ||||||||
|
glycosylphosphatidylinositol specific phospholipase D1 | 0.656 | 0.577 | 1.6E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.943 | 200 | 13 | 1991 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.100 | None | 0.976 | 80 | 0 | 1991 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.100 | None | 0.979 | 45 | 4 | 1991 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.100 | None | 1.000 | 45 | 0 | 1991 | 2019 | ||||||||
|
RAN binding protein 2 | 0.578 | 0.615 | 1.00 |
|
disease | 0.100 | None | 0.969 | 32 | 0 | 1991 | 2019 | ||||||||
|
MIA SH3 domain containing | 0.537 | 0.769 | 1.7E-05 |
|
disease | 0.100 | None | 0.975 | 32 | 0 | 1991 | 2019 | ||||||||
|
MAGE family member A1 | 0.601 | 0.462 |
|
disease | 0.400 | None | 0.903 | 29 | 0 | 1991 | 2017 | |||||||||
|
tyrosinase related protein 1 | 0.507 | 0.846 | 6.6E-25 |
|
disease | 0.400 | None | 1.000 | 29 | 1 | 1991 | 2019 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
disease | 0.100 | None | 1.000 | 23 | 0 | 1991 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 10 | 0.378 | 0.885 | 0.37 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 1991 | 2019 | ||||||||
|
zinc finger protein 654 | 0.582 | 0.500 | 1.00 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 1991 | 2014 |